​HOW TO FIND THE VENUE

DEEP TECH WEEK

​Welcome to the Premier Biotech Event of Deep Tech Week.

​Full speaker, panel, and showcase schedules to be announced.

​ EXPLORE THE CUTTING EDGE OF:

​·           AI & Gene Therapy

​·           Nanotechnology & Drug Delivery

​·           Diagnostics & Therapeutics

​·           Longevity & Regenerative Medicine

​·           Healthcare Innovation

​·           Venture Capital in a Rapidly Evolving Ecosystem

​·           State-of-the-Art Biomedical Sciences

​CONFIRMED SPEAKERS

​David Sinclair, PhD

​Professor of Genetics, Harvard Medical School

​Founding Director, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard

​Co-founder, Sirtris Pharmaceuticals (acquired by GSK for $720M)

​Co-founder of MetroBiotech, EdenRoc Sciences, Tally Health, and Life Biosciences

​Author of Lifespan: Why We Age and Why We Don't Have To

​Andrew Hessel

​Biotechnologist, Futurist, and Founder of the Human Genome Project-Write

​Chairman, Genome Project-write & Center of Excellence for Engineering Biology

​Founder, Humane Genomics & Former Distinguished Researcher in the Bio/Nano Programmable Matter department at Autodesk

​Expert in synthetic biology and biomanufacturing innovation

​Co-author, The Genesis Machine: Our Quest to Rewrite Life in the Age of Synthetic Biology 

​Ester Caffarel-Salvador, PhD

​Director, Strategic Innovation, Chiesi USA

​Biochemist | Scientific Advisor | Mentor | Consultant

​MIT's Innovator under 35 (2019) 

​Katie Kuo, PhD

​CEO & Founder, Atomistic Insights

​Computational Biophysicist | Chemist

​Creating Computational Approaches for Next-Generation Dynamic Protein Modeling

​Ileana Pirozzi, PhD

​Head of Healthcare Ventures, Lingotto Innovation ($6Bn AUM)

​Venture Capitalist | Bioengineer | Medical Engineer

​Previously: Medical researcher, scientist and operator with roles at OpenAI, Perkin Elmer, NASA, venture funds and early-stage startups; Applied research in medical robotics, cardiovascular engineering and artificial muscles @ Stanford

​Curtis Wu, MBA

​General Partner, Terran Applied

​Deep Tech & Life Sciences Investor | Former Biologics Manufacturing @ Amgen

​Previously: MBA @ Harvard, B.S. ChemE @ MIT

​James Lim, JD, MBA

​Investment Professional, In-Q-Tel (

​Deep Tech, Biotech, AI & Software Investor | National Security

​Previously: MBA, JD @ Harvard Business School & Harvard Law School

​Aaron Hsu, MHSc

​General Partner, Actual VC

​Investing in Science-First Companies to Scale Impact | Forbes 30 Under 30 (Retail & E-commerce, 2021)

​Previously: Co-Founder & CEO, ClearMask (Built and Scaled to $40MM ARR before Exit) | Biochemistry & Molecular Biology, Clinical Researcher, MHSc @ Johns Hopkins University

​Kristine Yu

​VP, Head of BD & Strategic Alliances, Arbor Biotechnologies; Partner, SummitBio Advisory

​Drug Developer | Company Builder | Corporate Strategist | Deal Maker for Advanced Therapies

​Previously: Novartis, Editas Medicines

​Nicole Fay, PhD

​Senior Director, Alliance Management, Nutcracker Therapeutics

​Molecular Biologist | Drug Discovery & Design | Personalized Therapeutics

​Making medicine more accessible and individualized via novel RNA therapeutic concepts

​Paramita Mishra

​CEO & Founder, Precigenetics

​Live, continuous single-cell biophotonics & multi-omics

​Previously: UPenn Computer Science, Computational Bio

​Andre Watson

​CEO & Founder, Ligandal

​Inventor (88 patents) | Forbes 30 Under 30 (Healthcare, 2021)

​Biomedical Engineer & Drug/Gene Delivery Nanoscientist  

​Additional Speakers TBA

​EVENT SCHEDULE:

​BRIEF NETWORKING

​12:00 12:25 PM

​OPENING REMARKS & A NOTE FROM OUR SPONSOR (ACTUAL.VC)

​PRELUDES TO THE FUTURE OF MEDICINE (LIGANDAL)

​12:25 - 12:30

​FIRESIDE CHAT: BIOMANUFACTURING, BIOSECURITY, AND THE FUTURE OF BIODEFENSE

​12:30 - 1 PM

​Featuring: Andrew Hessel & Andre Watson (Ligandal)

​LIGHTNING TALKS: FROM PREDICTION TO DX TO TX

​ATOMISTIC INSIGHTS: PROTEIN DYNAMICS FOR BREAKTHROUGH MEDICINES

​1 – 1:10 PM

​Featuring: Katie Kuo, PhD (Atomistic Insights)

​NON-INVASIVE, CONTINUOUS, SINGLE-CELL MULTI-OMIC DIAGNOSTICS OF THE FUTURE

​1:10 – 1:20 PM

​Featuring: Paramita Mishra (Precigenetics)

​FROM PROMISE TO PATIENT: DELIVERING PERSONALIZED THERAPIES WITH MICROFLUIDIC MANUFACTURING SOLUTIONS

​1:20 – 1:30 PM

​Featuring: Nicole Fay (Nutcracker Therapeutics)

​SPEED NETWORKING & MATCHMAKING

​1:30 – 2:00 PM

​PANEL: BRIDGING THE BIOTECH VALLEY OF DEATH: HOW VENTURE CAPITAL CAN DRIVE INNOVATION IN UNCERTAIN ECONOMIES

​2:00 - 2:30 PM

​Featuring: Ileana Pirozzi (Lingotto), Aaron Hsu (Actual VC), Curtis Wu (Terran Applied), James Lim (In-Q-Tel), Andre Watson (Ligandal)

​Moderated by Luila Zaimi (The Longevity Adaptation Foundation, Tech M&A @ Deutsche Bank)

​THE FUTURE OF PRECISION MEDICINE: HOW PHARMA CAN LEAD IN AN ERA OF CURATIVE THERAPIES

​2:30 – 3:00 PM

​Featuring: Ester Caffarel-Salvador (Chiesi), Kristine Yu (Arbor Bio)

​Moderated by Nicole Fay (Nutcracker Tx)

​FIRESIDE CHAT: NANOTECHNOLOGY, PRECISION GENE THERAPY, AND OUR FUTURE OF CURATIVE MEDICINE

​3:00 - 3:30 PM

​Featuring: Nicole Fay (Nutcracker Tx), Andre Watson (Ligandal)

​FEATURED SESSION 

​FIRESIDE CHAT: THE FUTURE OF LONGEVITY

​3:30 - 4:00 PM

​Featuring: David Sinclair (Harvard Medical School) & Andre Watson (Ligandal)